February 2006
Volume 47, Issue 2
Free
Glaucoma  |   February 2006
Semiquantitative Optic Nerve Grading Scheme for Determining Axonal Loss in Experimental Optic Neuropathy
Author Affiliations
  • Balwantray C. Chauhan
    From the Retina and Optic Nerve Research Laboratory and
    Departments of Ophthalmology and Visual Sciences, and
    Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; and
  • Terry L. LeVatte
    From the Retina and Optic Nerve Research Laboratory and
    Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; and
  • Krista L. Garnier
    Departments of Ophthalmology and Visual Sciences, and
  • François Tremblay
    From the Retina and Optic Nerve Research Laboratory and
    Departments of Ophthalmology and Visual Sciences, and
    Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; and
  • Iok-Hou Pang
    Alcon Research Ltd., Fort Worth, Texas.
  • Abbot F. Clark
    Alcon Research Ltd., Fort Worth, Texas.
  • Michele L. Archibald
    From the Retina and Optic Nerve Research Laboratory and
    Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada; and
Investigative Ophthalmology & Visual Science February 2006, Vol.47, 634-640. doi:https://doi.org/10.1167/iovs.05-1206
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Balwantray C. Chauhan, Terry L. LeVatte, Krista L. Garnier, François Tremblay, Iok-Hou Pang, Abbot F. Clark, Michele L. Archibald; Semiquantitative Optic Nerve Grading Scheme for Determining Axonal Loss in Experimental Optic Neuropathy. Invest. Ophthalmol. Vis. Sci. 2006;47(2):634-640. https://doi.org/10.1167/iovs.05-1206.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To describe and evaluate a semiquantitative optic nerve grading scheme for assessing axonal loss in endothelin (ET)-1-induced chronic optic neuropathy.

methods. Optic nerve cross-sections from both eyes of 39 Brown Norway rats unilaterally treated with various concentrations of ET-1 or physiological saline solution via a surgically implanted osmotic minipump were processed for light and transmission electron microscopy (TEM). The optic nerve damage grade, between 0 (no damage) and 10 (total damage), was based on the number of zones of approximately equal damage and the mean percentage of damage within each zone. Grading was performed under light microscopy by three observers and compared with axonal survival determined with TEM using two quantification methods: the sampling method, in which ∼10% of the section was counted, and the full-count method, in which the whole section was counted (n = 12). Axonal survival was expressed as a ratio of axon counts in the experimental to control eye. Before these comparisons, the inter- and intraobserver agreement rates were determined in another group of 85 and 12 ET-1-treated animals, respectively.

results. The interobserver κ was 0.66 (95% confidence interval [CI]: 0.58–0.74) for all eyes and 0.55 (95% CI: 0.43–0.67) for the experimental eyes only. The intraobserver κ was 0.80, 0.81, and 0.80 for all 24 eyes and 0.60, 0.64, and 0.71 for experimental eyes only. The correlation between damage grade in the experimental eye and axonal survival using the TEM sampling method (Spearman’s ρ = −0.677 for all animals and −0.827 for the subset of animals with full counts only) was lower than that with the full-count method (Spearman’s ρ = −0.926). When axonal survival was less than 0.7, the sampling method always underestimated the extent of damage.

conclusions. The grading scheme had good inter- and intraobserver agreement, and high correlation with the TEM methods. It is a practical and time-saving method, requiring less than 1 minute per nerve and is an alternative to sampling methods that can yield significant errors.

Experimental models of glaucoma are providing important clues for understanding the pathophysiology of glaucomatous optic nerve and retinal damage. In recent years, these models have also served to test pharmacological 1 2 3 4 5 6 and gene-based 7 8 9 interventions for decelerating or halting further loss of retinal ganglion cells (RGCs) initiated by the experimental injury. The assessment of neuronal loss in these models is a fundamental requirement of these experiments and several approaches to quantifying survival of RGCs or their axons in the optic nerve have been used. 
Retrograde labeling of the RGCs with a tracer dye is a commonly used technique in rodents for quantifying RGCs in wholemounted retinas. 10 11 For estimates based on manual counts, portions of the retina are imaged and analyzed. 12 Alternatively, automated image analysis methods have been used to sample the whole retina. 13 After comparison with the fellow or other control eyes, RGC survival can be estimated. Although this technique is valuable, it is relatively time-consuming if counts are performed manually. Furthermore, in long-term experiments, RGC labeling becomes faint, and some tracer dyes (e.g., Fluorogold; Fluorochrome, Denver, CO), are transported out of the RGC bodies. 14 To avoid this complication, tracer dyes are often introduced after the experimental insult and just before the animal is killed, 3 15 with the assumptions that labeled RGCs are viable and that all viable RGCs are labeled. 
Quantifying the number of surviving RGC axons is another commonly used technique in experimental glaucoma, though the temporal relationship between axonal and somal loss may be complex (Archibald ML, et al. IOVS 2001;42:ARVO Abstract 4440). 16 Cross sections of optic nerve are imaged by light or transmission electron microscopy (TEM). Similar to the quantification of RGCs, axon counts can be obtained by manual 17 or automated techniques. 18 19 20 Manual counting of axons is also time consuming, especially in nerves of nonhuman primates where a relatively large number of axons have to be counted compared with rodents, for a given proportion of the nerve. For these reasons, some investigators have described a qualitative or semiquantitative grade whereby optic nerve sections can be evaluated rapidly. 21 22 Morrison et al. 23 showed good agreement between a subjective nerve injury grade and axon counts in eight animals in whom one eye had experimental elevation of intraocular pressure (IOP). 
In this study we describe a semiquantitative ordinal 11-point grading scheme using light microscopy for the evaluation of optic nerves of rats treated chronically with endothelin (ET)-1 to induce RGC loss. 24 We compared this grading scheme to axon counts based on two manual methods using TEM: the sampling method, in which counts were derived from sampling approximately 10% of the nerve, and the full-count method, in which counts were derived from the entire nerve section. 
Materials and Methods
Animals
Adult male Brown Norway rats (250–300 g) were housed in a 12-hour light–dark cycle environment and given food and water ad libitum. All procedures complied with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and ethics approval was obtained from the Dalhousie University Committee on Laboratory Animals. Animals were anesthetized for surgery with a ketamine, xylazine, and acepromazine cocktail and killed with an overdose of pentobarbital sodium (240 mg/mL). Both drugs were given intraperitoneally. 
Model of ET-1-Induced Chronic Optic Neuropathy
Optic nerve damage was induced using a model, detailed elsewhere, 24 of RGC loss produced by a chronic delivery of ET-1. Briefly, an osmotic minipump (Durect Corp., Cupertino, CA) containing ET-1 dissolved in 0.1 mM physiological saline solution (PSS) was used to deliver 0.05, 0.1, 0.2, or 0.4 μg ET-1/d (corresponding to 3.3, 6.7, 13.4, and 26.8 μM, respectively) or PSS at a rate of 0.25 μL/hr to one optic nerve. One end of a silastic delivery tube was connected to the minipump, while the other was channeled through a hole in the orbital ridge and positioned approximately 1 mm behind the globe and just above (ensuring no contact with) the optic nerve. Each minipump contained sufficient perfusate for 28 days and minipumps were replaced where experiments exceeded this time period. The experimental procedure was performed on one eye only, and the fellow eye served as the untreated control. 
Tissue Preparation and Imaging
Animals were killed at various time points after minipump implantation, as a wide range of nerve damage was desired. Previous results have indicated a time-dependent loss of RGCs and their axons. 24 After enucleation, the optic nerve was cut approximately 1 mm behind the globe and the nerve stump fixed immediately in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) overnight. The stump was rinsed with the buffer and placed in 1% OsO4 for 2 hours and in 0.25% uranyl acetate for an additional 2 hours. The nerves were dehydrated with a series of acetones and embedded in epoxy medium (Epon Araldite; Mirivac, Halifax, NS, Canada). 
For analysis with TEM, nerves were thin sectioned (100–130 nm), poststained with 2% uranyl acetate, and viewed on an electron microscope (EM300; Philips, Eindhoven, The Netherlands). For the TEM sampling method, three or four (depending on the diameter of the nerve) equidistant micrographs (83 × 58 μm) from the center of the nerve were taken in each quadrant. For the TEM full-count method, a montage of the whole nerve section consisting of 40 to 50 micrographs was made in a subset of animals. For optic nerve grading with light microscopy, nerves were thick sectioned (∼1 μm) and stained with 1% p-phenylenediamine (Sigma-Aldrich, Oakville, ON, Canada). They were then rinsed in isopropanol, dried on a hotplate and coverslipped with a mounting medium (Eukitt; Electron Microscopy Sciences, Washington, PA), as previously described. 25  
Axon Quantification and Optic Nerve Damage Grade
Each micrograph obtained with TEM was printed on 12.5 × 12.5-cm paper with a print magnification of 4800. Axon counts were performed manually by a single observer. Criteria for viable axons included an intact myelin sheath, visible neurofilament, and absence of obvious swelling or shrinkage. The mesh grid used for TEM occupied 55% of the imaged area, and axon counts were extrapolated accordingly. Axonal survival was expressed as a ratio of axon counts in the experimental to fellow control eye. 
Optic nerve grading was performed under light microscopy. Similar to the criteria used with TEM, axonal damage was identified by degeneration, swelling, shrinkage, and replacement of axons by glial tissue. Using a 10× (NA 0.3) objective (Nikon, Mississauga, ON, Canada), so that the whole nerve was visible in the field of view, we first identified the number of zones where the damage was approximately equal and then made an approximation of the percentage of the nerve cross section occupied by each zone. Using a 40× (NA 0.75) objective, under which it was possible to resolve individual axons, we approximated the mean percentage of damage (using criteria stated above) within each zone. By summing the products of the mean percentage of damage within each zone and the area of the nerve occupied by the zone, we obtained a number between 0 and 1. This number was rounded to one decimal place and multiplied by 10 to obtain the damage grade. If the calculated damage grade was 0, but the nerve contained damaged axons (typically >20), the grade was changed to 1, as a nominal indication that the nerve was damaged. Figure 1shows illustrative examples of the grading scheme. The time required for grading a nerve was less than 1 minute and considerably less when the nerve was apparently normal. 
Optic nerves were graded by three independent observers. When all observers gave the same grade to a nerve, it was taken as the final grade. When two observers gave the same grade and the third observer was within 1 unit, the final grade was that given by the first two observers. In all other cases, the nerve was reexamined by all observers and a consensus grade was taken as the final grade. 
Only optic nerve damage grades from the experimental nerves were used when comparisons between the grading scheme and axon counts were made. This approach was taken to avoid the artificially high correlation obtained in close data clustering when control nerves are included. To help control for the potential influence of interanimal variability in axon counts, for both TEM methods, the proportion of surviving axons in experimental to control nerves was used in comparisons with optic nerve damage grade. 
Inter- and Intraobserver Variability of the Grading Scheme
Before grading the optic nerves, as described herein for the comparison study, the inter- and intraobserver variability of the grading scheme was determined for the three observers in a separate group of animals from a previous study. 24 The interobserver variability was determined in a total of 85 animals in whom one eye was treated chronically with ET-1, whereas the fellow eye served as the untreated control. The nerves were divided into eight sets containing 8 to 26 nerves, with each observer grading one set per session. The intraobserver variability was determined in one set of nerves from 12 animals graded by the same observer on three different days. The nerves were coded such that the observer was unaware of the status of the nerve (experimental or control). Each observer was also masked to the grades of the other observers as well as to his or her grades from previous sessions. κ statistics were determined for both inter- and intraobserver variability by using the subjective classification described by Landis and Koch 26 wherein 0.81 to 1.00, 0.61 to 0.80, 0.41 to 0.60, 0.21 to 0.40, 0.20 to 0.39, and less than 0 indicated almost perfect, substantial, moderate, fair, and poor agreement, respectively. 26  
Results
A total of 39 animals were used for the portion of the study comparing the optic nerve grading to axonal survival with the TEM sampling method. Both experimental and control eyes were available in all but one animal, in which the optic nerve section from the experimental nerve was not usable. Axon counts with the TEM full-count method were obtained in both eyes of 12 (31%) animals. Two, 5, 22, and 4 animals were treated with 0.05, 0.1, 0.2, and 0.4 μg ET-1/d respectively, whereas 6 were treated with PSS. Four, 11, 9, 5, and 10 animals were killed after 10, 21, 42, 63, and 84 days, respectively. 
The agreement rates among the three observers for the eight sets of nerves is shown in Table 1 . The mean ± SD interobserver κ for the eight sets of nerves was 0.67 ± 0.09. There was no obvious trend in interobserver variability with grading session (Spearman’s ρ = 0.571; P = 0.139). The interobserver κ for all 170 nerves over the eight sets was 0.66 (95% CI: 0.58–0.74). When the control eyes were removed from the analyses, the agreement rates were lower (Table 1) . The mean ± SD interobserver κ for the eight sets of nerves was 0.55 ± 0.21, whereas the interobserver κ for all experimental nerves over the eight sets was 0.55 (95% CI: 0.43–0.67). The intraobserver κ for the three observers were 0.80, 0.81, and 0.80 for all eyes and 0.60, 0.64 and 0.71, respectively, for experimental eyes only. The interobserver agreement results are shown in Table 2
The median optic nerve damage grade in the 38 experimental eyes used for the comparison study was 2, with a range from 0 to 10. Thirty-eight (97%) of the 39 control nerves had a damage grade of 0, whereas 1 (3%) had a grade of 1. There was a good relationship between the optic nerve damage grade and axonal survival with the TEM sampling method (Spearman’s ρ = −0.677; P < 0.001; Fig. 2 ); however, there was considerable dispersion in the damage grades with mild axonal loss, or there was considerable dispersion in axonal loss estimated with the sampling method for a given damage grade. The relationship between damage grade and axonal survival with the TEM full-count method is shown in Figure 3 (Spearman’s ρ = −0.926; P < 0.001). The association between damage grade and axonal survival using the full full-count method was significantly higher than that with the sampling method (P = 0.032). When only the subset of 12 animals in whom axonal survival was obtained with both methods was analyzed, the association between damage grade and axonal survival with the full-count method (Spearman’s ρ = −0.926) was higher than that with the sampling method (Spearman’s ρ = −0.827, P < 0.001), although the differences did not reach statistical significance (P = 0.338). 
In nerves that had axonal survival determined by both TEM methods, the sampling method sampled a mean ± SD of 10.1% ± 2.0% and 9.9% ± 1.4% of the total number of axons in the experimental and control eyes, respectively. In these animals, the full-count method yielded a mean ± SD of 68,330 ± 40,630 axons in the experimental eyes and 127,190 ± 11,400 axons in the control eyes. The regression equation describing the relationship between axonal survival estimates using the two methods (Fig. 4)yielded a slope of 0.839 and an intercept of 0.126. A Bland-Altman plot showing the difference versus mean of the two methods (Fig. 5)shows that when the mean ratio of axonal survival was less than 0.7, the sampling method always underestimated the extent of damage, approaching differences in survival ratio of 0.2 in some cases. When the extent of damage was slight, the sampling method yielded survival ratios that were generally closer to those of the full-count method. 
Discussion
An estimate of axonal survival in experimental optic neuropathy is a key measure of the degree of induced damage and a fundamental determinant of the efficacy of interventions used to halt or ameliorate the damage. Automated computer-based techniques for axon counting have been used for many years 18 19 20 ; however, these techniques require size and shape parameters to be defined for the counts to be accurate. The experimenter may then have to perform manual checks to ensure that the predefined parameters did not omit viable axons or included nonaxons or other artifacts in the counts. In addition to size and shape criteria, viable axons are identified by an intact myelin sheath, visible neurofilament, and absence of obvious swelling, shrinkage and myelin debris. 23 27 Because these latter parameters are difficult to automate, some investigators have continued to perform manual counts. 
Although methods that sample the entire optic nerve cross- section ultimately provide the most accurate measures, manual counting is time consuming, even in rodents, which have less than 10% of the axons in primates. In this study, performing manual counts using the TEM sampling method required approximately 1 hour per animal, whereas the full-count method required approximately 5 hours. In experiments in which dozens of animals may be needed, manual counting is obviously impractical and tedious. Optic nerve damage grading schemes, 21 22 such as the semiquantitative one described in this study may be a practical alternative. 
When both nerves from a large number of animals were graded by three independent observers, the interobserver agreement was substantial. The agreement rate decreased to moderate when only experimental eyes were graded. This finding is not surprising, because the inclusion of normal fellow control eyes, which almost invariably had damage grades of 0, leads to a higher agreement rate. There is a paucity of published reports on inter- and intraobserver grading schemes for optic nerve damage. Using a 5-point (1–5) damage scale, Jia et al. 21 reported κ of 0.90 (95% CI: 0.76–1.03), indicating almost perfect agreement, in a group of 17 animals that had unilateral experimental elevation of IOP. Although the respective κ in the present study was lower (0.66; 95% CI: 0.58–0.74), it is important to note that the values between the two studies may be difficult to compare, because the grading scheme described here was an 11-point (0–10) scale and that the distribution of optic nerve damage was different between the studies. Twenty-nine (85%) of the nerves in the study of Jia et al. 21 had a grading of either 1 or 5, which would yield a higher κ. In the present study the intraobserver agreement was considerably higher than the respective interobserver agreement for all eyes and experimental eyes only. To the best of our knowledge, there are no other published reports on intraobserver agreement rates for axon-based optic nerve damage grading schemes. 
Although there was a statistically significant relationship between the damage grade and axonal survival with the TEM sampling method, there was considerable variation in damage grades for a given ratio of axonal survival or vice versa. Hence, either the grading scheme does not accurately reflect the degree of axonal loss, or the TEM sampling method yields an inaccurate estimate of axonal survival. To address this question, the damage grade was correlated to the TEM full-count method. The fact that this analysis showed a considerably higher correlation between damage grade and axonal survival suggests that the TEM sampling method may yield suboptimal results. Indeed, if the TEM full-count method is assumed to be the gold standard, the sampling method yielded errors (underestimation of damage) in axonal survival that approached 0.2 in moderately damaged nerves. The grid mesh in TEM sections occupied 55% of the section; hence, even for the full-count method, only 45% of the nerve was used. As the sampling method sampled ∼10% of the axons, only 4.5% of the nerve was used in the counts. In normal nerves, or in nerves with completely diffuse axonal loss, sampling a small proportion of the nerve may yield reasonably accurate estimates with acceptable standard errors, as was shown recently by Cull et al. 28 However, in eyes with nonuniform axonal loss across the nerve section, the undersampling is likely to lead to significant errors. In this situation, axon counts in a larger proportion of the nerve may have to be performed to increase accuracy, making the task even more time consuming. 
Many improvements to the optic nerve grading scheme could have been made. For example, the addition of a 100× oil-immersion objective would have allowed resolution of finer detail and application of criteria even closer to those used for counting axons with TEM; however, we thought that the additional time and decision rules would cease to make the technique rapid. We also elected not to image and print a micrograph, as including the whole nerve section in the image would entail digitally enlarging the view with the 10× objective. Obtaining the same magnification optically produced far superior results, but capturing these images, printing micrographs, and constructing a montage for each nerve would again add significant time. For these reasons, the grading was performed under the microscope by a step-wise process with two microscope objectives. The major limitation of the grading scheme is the possibility that light microscopy may not be able to resolve the smallest axons, explaining why in previous studies total axon counts with light microscopy are lower than those obtained with TEM. 23 Light microscopy may also not allow a detailed view of the axoplasm, and therefore damaged or degenerating axons that have not yet been phagocytosed may be included as viable axons in the evaluation. Although the grading scheme is quick, the ability to standardize the technique across different laboratories is unknown. Hence, for comparison of results between laboratories using grading schemes, it may be necessary to calibrate the damage grades with axonal loss using counting methods so that the results can be interpreted correctly. 
In summary, we have described and evaluated a semiquantitative scheme for grading axonal damage in rat optic nerves. With modifications, this scheme can be applied to other species. Optic nerves can be graded under light microscopy in less than 1 minute per nerve, yielding high correlation to axonal survival measured with the TEM full-count method, which requires ∼2.5 hours. Given that axon counting with TEM is time consuming and may result in significant errors when sampling methods are used, the grading scheme may provide considerable advantages in evaluating the experimental optic neuropathies. 
 
Figure 1.
 
Optic nerve grading scheme with four illustrative examples of various levels of nerve damage. (A) Low-power light micrographs; (B) schematic of the light micrographs in (A), illustrating the zones with equivalent damage and calculation of damage grade; and (C) representative high-power light micrographs of one of the zones in the respective nerves with approximately 0%, 30%, 60%, and 100% damage, respectively. Scale bars: (A) 100 μm; (C) 30 μm.
Figure 1.
 
Optic nerve grading scheme with four illustrative examples of various levels of nerve damage. (A) Low-power light micrographs; (B) schematic of the light micrographs in (A), illustrating the zones with equivalent damage and calculation of damage grade; and (C) representative high-power light micrographs of one of the zones in the respective nerves with approximately 0%, 30%, 60%, and 100% damage, respectively. Scale bars: (A) 100 μm; (C) 30 μm.
Table 1.
 
Interobserver Agreement Rates for Optic Nerve Damage Score
Table 1.
 
Interobserver Agreement Rates for Optic Nerve Damage Score
Set All Eyes Experimental Eyes Only
n All Observers Agree ≥2 Observers Agree n All Observers Agree ≥2 Observers Agree
1 26 19 (73) 24 (92) 13 6 (46) 11 (85)
2 24 14 (58) 22 (92) 12 3 (25) 10 (83)
3 22 17 (77) 21 (95) 11 6 (55) 10 (91)
4 26 15 (58) 24 (92) 13 3 (23) 11 (85)
5 26 19 (73) 25 (96) 13 8 (62) 12 (92)
6 12 10 (83) 12 (100) 6 5 (83) 6 (100)
7 8 6 (75) 8 (100) 4 3 (75) 4 (100)
8 26 21 (81) 26 (100) 13 11 (85) 13 (100)
Total 170 121 (71) 162 (95) 85 45 (53) 77 (91)
Table 2.
 
Intraobserver Agreement Rates for Optic Nerve Damage
Table 2.
 
Intraobserver Agreement Rates for Optic Nerve Damage
Observer All Eyes Experimental Eyes Only
n All Ratings Agree ≥2 Ratings Agree n All Ratings Agree ≥2 Ratings Agree
1 24 19 (79) 24 (100) 12 7 (58) 12 (100)
2 24 19 (79) 24 (100) 12 7 (58) 12 (100)
3 24 19 (79) 24 (100) 12 8 (67) 12 (100)
Figure 2.
 
Scattergram of axonal survival estimated by the TEM sampling method and optic nerve damage grade in the experimental eyes.
Figure 2.
 
Scattergram of axonal survival estimated by the TEM sampling method and optic nerve damage grade in the experimental eyes.
Figure 3.
 
Scattergram of axonal survival estimated by the TEM full-count method and optic nerve damage grade in the experimental eyes.
Figure 3.
 
Scattergram of axonal survival estimated by the TEM full-count method and optic nerve damage grade in the experimental eyes.
Figure 4.
 
Relationship between axonal survival estimated by the TEM sampling and full-count methods (R 2 = 0.859; P < 0.001). Best linear fit (dashed line) and line of equality (solid line).
Figure 4.
 
Relationship between axonal survival estimated by the TEM sampling and full-count methods (R 2 = 0.859; P < 0.001). Best linear fit (dashed line) and line of equality (solid line).
Figure 5.
 
Bland-Altman plot of axonal survival estimated by the TEM sampling and full-count methods.
Figure 5.
 
Bland-Altman plot of axonal survival estimated by the TEM sampling and full-count methods.
MorrisonJC, NylanderKB, LauerAK, CepurnaWO, JohnsonE. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma. Invest Ophthalmol Vis Sci. 1998;39:526–531. [PubMed]
ChaudharyP, AhmedF, SharmaSC. MK801-a neuroprotectant in rat hypertensive eyes. Brain Res. 1998;792:154–158. [CrossRef] [PubMed]
NeufeldAH, SawadaA, BeckerB. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944–9948. [CrossRef] [PubMed]
YolesE, WheelerLA, SchwartzM. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65–73. [PubMed]
SchoriH, KipnisJ, YolesE, et al. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci USA. 2001;98:3398–3403. [CrossRef] [PubMed]
WoldeMussieE, YolesE, SchwartzM, RuizG, WheelerLA. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11:474–480. [CrossRef] [PubMed]
McKinnonSJ, LehmanDM, TahzibNG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther. 2002;5:780–787. [CrossRef] [PubMed]
MartinKR, QuigleyHA, ZackDJ, et al. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2003;44:4357–4365. [CrossRef] [PubMed]
ZhouY, PernetV, HauswirthWW, Di PoloA. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005;12:402–412. [CrossRef] [PubMed]
Vidal-SanzM, BrayGM, Villegas-PerezMP, ThanosS, AguayoAJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci. 1987;7:2894–2909. [PubMed]
ThanosS, KaczaJ, SeegerJ, MeyJ. Old dyes for new scopes: the phagocytosis-dependent long-term fluorescence labelling of microglial cells in vivo. Trends Neurosci. 1994;17:177–182. [CrossRef] [PubMed]
Selles-NavarroI, Villegas-PerezMP, Salvador-SilvaM, Ruiz-GomezJM, Vidal-SanzM. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals: a quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002–2014. [PubMed]
DaniasJ, ShenF, GoldblumD, et al. Cytoarchitecture of the retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci. 2002;43:587–594. [PubMed]
KobbertC, AppsR, BechmannI, et al. Current concepts in neuroanatomical tracing. Prog Neurobiol. 2000;62:327–351. [CrossRef] [PubMed]
MittagTW, DaniasJ, PohorenecG, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000;41:3451–3459. [PubMed]
LibbyRT, LiY, SavinovaOV, et al. Susceptibility to neurodegeneration in a glaucoma is modified by bax gene dosage. PLoS Genet. 2005;1:E4. [CrossRef]
BalazsiAG, RootmanJ, DranceSM, SchulzerM, DouglasGR. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol. 1984;97:760–766. [CrossRef] [PubMed]
QuigleyHA, SanchezRM, DunkelbergerGR, L’HernaultNL, BaginskiTA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913–920. [PubMed]
JonasJB, Muller-BerghJA, Schlotzer-SchrehardtUM, NaumannGO. Histomorphometry of the human optic nerve. Invest Ophthalmol Vis Sci. 1990;31:736–744. [PubMed]
MikelbergFS, YidegiligneHM, WhiteVA, SchulzerM. Relation between optic nerve axon number and axon diameter to scleral canal area. Ophthalmology. 1991;98:60–63. [CrossRef] [PubMed]
JiaL, CepurnaWO, JohnsonEC, MorrisonJC. Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci. 2000;41:1380–1385. [PubMed]
Levkovitch-VerbinH, MartinKR, QuigleyHA, et al. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transsection. J Glaucoma. 2002;11:396–405. [CrossRef] [PubMed]
MorrisonJC, JohnsonEC, CepurnaW, JiaL. Understanding mechanisms of pressure-induced optic nerve damage. Prog Retin Eye Res. 2005;24:217–240. [CrossRef] [PubMed]
ChauhanBC, LeVatteTL, JollimoreCA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144–152. [CrossRef] [PubMed]
HollanderH, VaalandJL. A reliable staining method for semi-thin sections in experimental neuroanatomy. Brain Res. 1968;10:120–126. [CrossRef] [PubMed]
LandisJR, KochGG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. [CrossRef] [PubMed]
ChauhanBC, PanJ, ArchibaldML, et al. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci. 2002;43:2969–2976. [PubMed]
CullG, CioffiGA, DongJ, HomerL, WangL. Estimating normal optic nerve axon numbers in non-human primate eyes. J Glaucoma. 2003;12:301–306. [CrossRef] [PubMed]
Figure 1.
 
Optic nerve grading scheme with four illustrative examples of various levels of nerve damage. (A) Low-power light micrographs; (B) schematic of the light micrographs in (A), illustrating the zones with equivalent damage and calculation of damage grade; and (C) representative high-power light micrographs of one of the zones in the respective nerves with approximately 0%, 30%, 60%, and 100% damage, respectively. Scale bars: (A) 100 μm; (C) 30 μm.
Figure 1.
 
Optic nerve grading scheme with four illustrative examples of various levels of nerve damage. (A) Low-power light micrographs; (B) schematic of the light micrographs in (A), illustrating the zones with equivalent damage and calculation of damage grade; and (C) representative high-power light micrographs of one of the zones in the respective nerves with approximately 0%, 30%, 60%, and 100% damage, respectively. Scale bars: (A) 100 μm; (C) 30 μm.
Figure 2.
 
Scattergram of axonal survival estimated by the TEM sampling method and optic nerve damage grade in the experimental eyes.
Figure 2.
 
Scattergram of axonal survival estimated by the TEM sampling method and optic nerve damage grade in the experimental eyes.
Figure 3.
 
Scattergram of axonal survival estimated by the TEM full-count method and optic nerve damage grade in the experimental eyes.
Figure 3.
 
Scattergram of axonal survival estimated by the TEM full-count method and optic nerve damage grade in the experimental eyes.
Figure 4.
 
Relationship between axonal survival estimated by the TEM sampling and full-count methods (R 2 = 0.859; P < 0.001). Best linear fit (dashed line) and line of equality (solid line).
Figure 4.
 
Relationship between axonal survival estimated by the TEM sampling and full-count methods (R 2 = 0.859; P < 0.001). Best linear fit (dashed line) and line of equality (solid line).
Figure 5.
 
Bland-Altman plot of axonal survival estimated by the TEM sampling and full-count methods.
Figure 5.
 
Bland-Altman plot of axonal survival estimated by the TEM sampling and full-count methods.
Table 1.
 
Interobserver Agreement Rates for Optic Nerve Damage Score
Table 1.
 
Interobserver Agreement Rates for Optic Nerve Damage Score
Set All Eyes Experimental Eyes Only
n All Observers Agree ≥2 Observers Agree n All Observers Agree ≥2 Observers Agree
1 26 19 (73) 24 (92) 13 6 (46) 11 (85)
2 24 14 (58) 22 (92) 12 3 (25) 10 (83)
3 22 17 (77) 21 (95) 11 6 (55) 10 (91)
4 26 15 (58) 24 (92) 13 3 (23) 11 (85)
5 26 19 (73) 25 (96) 13 8 (62) 12 (92)
6 12 10 (83) 12 (100) 6 5 (83) 6 (100)
7 8 6 (75) 8 (100) 4 3 (75) 4 (100)
8 26 21 (81) 26 (100) 13 11 (85) 13 (100)
Total 170 121 (71) 162 (95) 85 45 (53) 77 (91)
Table 2.
 
Intraobserver Agreement Rates for Optic Nerve Damage
Table 2.
 
Intraobserver Agreement Rates for Optic Nerve Damage
Observer All Eyes Experimental Eyes Only
n All Ratings Agree ≥2 Ratings Agree n All Ratings Agree ≥2 Ratings Agree
1 24 19 (79) 24 (100) 12 7 (58) 12 (100)
2 24 19 (79) 24 (100) 12 7 (58) 12 (100)
3 24 19 (79) 24 (100) 12 8 (67) 12 (100)
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×